Department News | January 30, 2025
The Center for Novel Therapeutics in Addiction Psychiatry is on track to start enrolling participants in a clinical trial assessing the safety, risk, and benefits of psilocybin for treating military veterans and first responders who have both posttraumatic stress disorder and alcohol use disorder.